Introduction to Cost-Effectiveness Analysis for Clinicians

被引:0
|
作者
Cape, Jennifer D. [1 ,2 ]
Beca, Jaclyn M. [1 ,2 ]
Hoch, Jeffrey S. [1 ,2 ,3 ]
机构
[1] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[2] Canc Care Ontario, Pharmacoecon Res Unit, Toronto, ON, Canada
[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As health care expenditures in Canada continue to increase annually, pressure rises to contain spending. Clinicians are partially responsible for cost containment and can help optimize spending by utilizing more cost-effective interventions. An understanding of economic evaluations, particularly cost-effectiveness analysis, will help physicians make well-informed decisions when choosing between different treatments for their patients. This paper describes different types of economic evaluations with a focus on cost-effectiveness analysis. A hypothetical study is included to illustrate how a cost-effectiveness analysis evaluation is performed. By understanding and considering the economic value of appropriate interventions, clinicians can aim to provide evidence-based care for their patients and the population as a whole.
引用
收藏
页码:103 / 105
页数:3
相关论文
共 50 条
  • [1] Cost-effectiveness analysis for clinicians
    Hill, Suzanne R.
    [J]. BMC MEDICINE, 2012, 10
  • [2] Cost-effectiveness analysis for clinicians
    Suzanne R Hill
    [J]. BMC Medicine, 10
  • [3] Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians
    Gupta, Nidhi
    Verma, Rohan
    Dhiman, Radha K.
    Rajsekhar, Kavitha
    Prinja, Shankar
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (02) : 177 - 184
  • [4] Relevance of cost-effectiveness analysis to clinicians and policy makers
    Detsky, Allan S.
    Laupacis, Andreas
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02): : 221 - 224
  • [5] COST-EFFECTIVENESS ANALYSIS AND COST-BENEFIT-ANALYSIS - AN INTRODUCTION
    YATES, BT
    [J]. BEHAVIORAL ASSESSMENT, 1985, 7 (03): : 207 - 234
  • [6] Introduction to the special issue on cost-effectiveness analysis
    Bertrand, Jane T.
    [J]. JOURNAL OF HEALTH COMMUNICATION, 2006, 11 : 3 - 6
  • [7] An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics
    Phillips, KA
    Veenstra, D
    Van Bebber, S
    Sakowski, J
    [J]. PHARMACOGENOMICS, 2003, 4 (03) : 231 - 239
  • [8] Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran
    Javanbakht, Mehdi
    Moradi-Lakeh, Maziar
    Yaghoubi, Mohsen
    Esteghamati, Abdoulreza
    Ghanaie, Roxana Mansour
    Mahmoudi, Sussan
    Shamshiri, Ahmad-Reza
    Zahraei, Seyed Mohsen
    Baxter, Louise
    Shakerian, Sareh
    Chaudhri, Irtaza
    Fleming, Jessica A.
    Munier, Aline
    Baradaran, Hamid R.
    [J]. VACCINE, 2015, 33 : A192 - A200
  • [9] COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIA
    De la Hoz, F.
    Alvis, N.
    Gamboa, O.
    Castaneda, C.
    Paternina, A.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A118 - A118
  • [10] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744